The following are notable drug approvals for July 2025.

Patients with SSc vs controls showed a greater prevalence of WMH on brain MRIs, particularly in deep white matter regions.

The FDA is reviewing a nasal spray formulation of bumetanide (RSQ-777), a loop diuretic, for the treatment of edema associated with congestive heart failure (CHF), as well as hepatic and renal disease ...

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

The least affluent and most non-Hispanic Black-concentrated areas had significantly higher advanced-to-localized incidence rate ratios for breast and cervical cancer. HealthDay News — People living in ...

While most cases of bug bites can be managed at home, some symptoms are more serious and should prompt patients to seek medical care.

The incidence of new-onset IA was higher after Lyme disease diagnosis vs influenza, especially during the first year postinfection.

The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to severely active rheumatoid arthritis.

Exercise may reduce VF progression among older adults, but vitamin D3 and omega-3 supplementation do not appear to impact rates of new or total VF.

Credit: Getty Images This in-depth feature explores the challenges and controversies surrounding the diagnosis and management of PANDAS. Pediatric autoimmune neuropsychiatric disorders associated with ...

Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population.

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.